{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:19:55Z","timestamp":1771651195216,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":2071,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00c3\u00a7\u00c3\u00a3o Carlos Chagas Filho de Amparo \u00c3\u00a0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00c3\u00a7\u00c3\u00a3o de Amparo \u00c3\u00a0 Pesquisa do Estado de S\u00c3\u00a3o Paulo","doi-asserted-by":"publisher","award":["CEPID 2013\/08135-2"],"award-info":[{"award-number":["CEPID 2013\/08135-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00c3\u00a7\u00c3\u00a3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00c3\u00adfico e Tecnol\u00c3\u00b3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.micinf.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T19:15:30Z","timestamp":1521746130000},"page":"312-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Trypanosoma cruzi infection of human induced pluripotent stem cell-derived cardiomyocytes: an in\u00a0vitro model for drug screening for\u00a0Chagas disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Leonardo","family":"da Silva Lara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Andrade-Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Magalh\u00e3es Calvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-0985","authenticated-orcid":false,"given":"Juliana","family":"Borsoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thabata","family":"Lopes Alberto Duque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Henriques-Pons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirian Claudia","family":"Souza Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0002-725X","authenticated-orcid":false,"given":"Lygia","family":"Veiga Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2018.03.002_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.actatropica.2015.04.014","article-title":"Economic evaluation of Chagas disease screening in Spain","volume":"148","author":"Imaz-Iglesia","year":"2015","journal-title":"Acta Trop"},{"key":"10.1016\/j.micinf.2018.03.002_bib2","volume":"vol. 1","author":"World Health Organization (WHO)","year":"2015"},{"key":"10.1016\/j.micinf.2018.03.002_bib3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/AAC.01401-12","article-title":"Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic Chagas disease","volume":"57","author":"Pinazo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.micinf.2018.03.002_bib4","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas' disease","volume":"370","author":"Molina","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2018.03.002_bib5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of benznidazole for chronic chagas' cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2018.03.002_bib6","first-page":"1","volume":"vol. 6","author":"Drugs for Neglected Diseases initiative (DNDi)","year":"2016"},{"key":"10.1016\/j.micinf.2018.03.002_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.micinf.2018.03.002_bib8","first-page":"114","article-title":"Lost in translation: animal models and clinical trials in cancer treatment","volume":"6","author":"Mak","year":"2014","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.micinf.2018.03.002_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrd4708","article-title":"Stem-cell discovery platforms yield first clinical candidates","volume":"14","author":"Mullard","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.micinf.2018.03.002_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu205","article-title":"Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells","volume":"104","author":"Han","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.micinf.2018.03.002_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.micinf.2018.03.002_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003552","article-title":"Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy","volume":"4","author":"Sun","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.micinf.2018.03.002_bib13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCRESAHA.115.303810","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes as an in\u00a0vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform","volume":"115","author":"Sharma","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.micinf.2018.03.002_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm.4087","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity","volume":"22","author":"Burridge","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2018.03.002_bib15","series-title":"World health statistics 2016","first-page":"1","author":"World Health Organization (WHO)","year":"2016"},{"key":"10.1016\/j.micinf.2018.03.002_bib16","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/1873-3468.12285","article-title":"Inherited heart disease - what can we expect from the second decade of human iPS cell research?","volume":"590","author":"Bellin","year":"2016","journal-title":"FEBS Lett"},{"key":"10.1016\/j.micinf.2018.03.002_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11886-017-0842-1","article-title":"Untangling the biology of genetic cardiomyopathies with pluripotent stem cell disease models","volume":"19","author":"Buikema","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.micinf.2018.03.002_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djp440","article-title":"Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention","volume":"102","author":"Albini","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.micinf.2018.03.002_bib19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/0960327107084540","article-title":"Early nifurtimox-induced biochemical and ultrastructural alterations in rat heart","volume":"26","author":"Bartel","year":"2007","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.micinf.2018.03.002_bib20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1590\/S0074-02762008000600007","article-title":"Benznidazole biotransformation in rat heart microsomal fraction without observable ultrastructural alterations: comparison to Nifurtimox-induced cardiac effects","volume":"103","author":"Mecca","year":"2008","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.micinf.2018.03.002_bib21","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1126\/science.273.5277.969","article-title":"Cure of short- and long-term experimental Chagas' disease using D0870","volume":"273","author":"Urbina","year":"1996","journal-title":"Science (80- )"},{"key":"10.1016\/j.micinf.2018.03.002_bib22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/oxfordjournals.jac.a002691","article-title":"Termination of development of D0870","volume":"47","author":"Williams","year":"2001","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.micinf.2018.03.002_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/em.21839","article-title":"Unveiling Benznidazole's mechanism of action through overexpression of DNA repair proteins in Trypanosoma cruzi","volume":"55","author":"Raj\u00e3o","year":"2014","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.micinf.2018.03.002_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.stemcr.2015.01.002","article-title":"Human iPSC-derived hepatocyte-like cells support plasmodium liver-stage infection in\u00a0vitro","volume":"4","author":"Ng","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.micinf.2018.03.002_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.micinf.2016.03.012","article-title":"Use of human induced pluripotent stem cell-derived neurons as a model for Cerebral Toxoplasmosis","volume":"18","author":"Tanaka","year":"2016","journal-title":"Microb Infect"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645791830073X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645791830073X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:35:22Z","timestamp":1761143722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S128645791830073X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S128645791830073X"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2018.03.002","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trypanosoma cruzi infection of human induced pluripotent stem cell-derived cardiomyocytes: an in\u00a0vitro model for drug screening for\u00a0Chagas disease","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}